Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 111, Issue 1, 292-301, January 1, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus–encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells
Blood Flavell et al. 111: 292

Supplemental materials for: Flavell et al

Files in this Data Supplement:

  • Table S1. EBV-regulated genes in KMH2 (XLS, 627 KB)

  • Table S2. EBV-regulated genes in L591 (XLS, 633 KB)

  • Figure S1. Q-PCR analysis of PTPRK expression in HL cells (JPG, 36.8 KB) -
    (A) Downregulation of PTPRK mRNA expression in KM-H2 cells infected with EBV (KM-H2-EBV) compared with control KM-H2 cells (KM-H2-neo). (B) Downregulation of PTPRK expression in EBV-positive parental L591 cells compared with their EBV-negative counterparts (L591-SD3). (C) EBNA1 expression in EBV-negative cells was alone sufficient to induce the downregulation of PTPRK mRNA expression. Shown here is data for KM-H2 cells. These data provide confirmation of the semi-quantitative PCR analysis shown in Figure 1 of the main paper.





  • Figure S2. Q-PCR analysis of PTPRK and Smad2 in HL cells (JPG, 22.8 KB) -
    EBV infection (left panel) or EBNA1 expression (right panel) in EBV-negative HL cell lines had no effect on Smad2 mRNA levels. Shown here is data for KM-H2 cells. These findings provide confirmation of the semi-quantitative PCR analysis of Smad2 RNA reported in Figure 2B of the main paper.





  • Figure S3. Q-PCR analysis following knockdown of Smad2 in KMH2 neo cells (JPG, 26.0 KB) -
    Depletion of Smad2 expression in EBV-negative KMH2 cells following knockdown with siRNA is confirmed by Q-PCR (left panel). This led to the down-regulation of PTPRK expression (right panel). These results confirm the semi-quantitative PCR analysis reported in Figure 4 of the main paper.





  • Figure S4. Immunoblotting for EBNA1 (JPG, 11.8 KB) -
    Left panel: EBNA1 protein expression is higher in the lymphoblastoid cell line X50-7 than in KM-H2-EBV and EBV-positive L591 cells. Right panel: EBNA1 protein expression in HL cells transfected with EBNA1 is similar to that observed in X50-7. We conclude that EBNA1 is overexpressed in transfected cell lines relative to EBV-infected HL cells. The different size of EBNA1 in the transfected cells reflects the well-described variation in the length of EBNA1 between different EBV isolates.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020